Abstract—
Cardiotoxicity, a well-recognized side effect of anthracycline antibiotics limits their use in the treatment of malignant processes in some patients. The review considers the main causes of the cardiomyocyte susceptibility to the damaging effect of anthracyclines, primarily associated with increased free radical processes. Currently, research is widely carried out to find ways to reduce anthracycline cardiotoxicity, in particular, the use of cardioprotective agents in the complex treatment of tumors. Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) have been shown to improve the function and metabolism of the cardiovascular system under various pathological conditions, therefore, it is proposed to use statins to reduce cardiotoxic complications of chemotherapy. Statins exhibit direct (hypolipidemic) and pleiotropic effects determined by inhibition of mevalonic acid synthesis and downstream biochemical cascades mediating their cardioprotective properties. The main point of intersection of the pharmacological activity of anthracyclines and statins is their ability to regulate the functioning of small GTPases of the Rho family: anthracyclines and statins cause opposite effects on the Rho proteins. The effect of statins on the modification and membrane dislocation of Rho proteins mediates their indirect antioxidant, anti-inflammatory, endothelioprotective, and antiapoptotic effects. Special attention in the review is paid to the mechanism of statin inhibition of the doxorubicin blockade of the DNA-topoisomerase complex, which may be important for prevention of the cardiotoxic damage during chemotherapy. At the same time, it should be noted that the use of statins can be accompanied by adverse side effects: provocation of increased insulin resistance and glucose tolerance, which often becomes the reason for their elimination from therapeutic schemes in patients with disorders of carbohydrate metabolism, so further research in this direction is clearly needed. Analysis of data on the antitumor effect of statins, their ability to sensitize the tumor to treatment with cytostatics showed that the relationship between anthracycline antibiotics and statins is characterized not only by antagonism, but also in some cases by synergism. Despite some adverse effects, statins are among the most promising cardio- and vasoprotectors for the use in anthracycline cardiomyopathy.
Similar content being viewed by others
REFERENCES
Zamorano, J.L., Lancellotti, P., Muñoz, D.R., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Le-nihan, D.J., Lip, G.Y.H., Lyon, A.R., Fernandez, T.L., Mohty, D., Piepoli, M.F., Tamargo, J., Torbicki, A., and Suter, T.M., Russian Journal of Cardiology, 2017, vol. 143, no. 3, pp. 105–139. https://doi.org/10.15829/1560-4071-2017-3-105-139
Gendlin, G.E., Emelina, E.I., Nikitin, I.G., and Vasyuk, Yu.A., Russian Journal of Cardiology, 2017, vol. 143, no. 3, pp. 145–154.
Klinnikova, M.G., Lushnikova, E.L., Koldy-sheva, E.V., Tolstikova, T.G., Sorokina, I.V., Yuzhik, E.I., and Mzhelskaya, M.M., Bulletin of Experimental Biology and Medicine, 2016, vol. 162, no. 8, pp. 247–252.
Lushnikova, E.L., Klinnikova, M.G., Molodykh, O.P., and Nepomnyashchikh, L.M., Bulletin of Experimental Biology and Medicine, 2005, vol. 139, no. 4, pp. 470–475.
Nepomnyashchikh, L.M., Lushnikova, E.L., Klinnikova, M.G., and Molodykh, O.P., Siberian Journal of Oncology, 2011, vol. 46, no. 4, pp. 30–35.
Vejpongsa, P. and Yeh, E.T.H., Clin. Pharmacol. Ther., 2014, vol. 95, no. 1, pp. 45–52. https://doi.org/10.1038/clpt.2013.201
Tacar, O. and Dass, C.R., J. Pharmacy Pharmacol., 2013, vol. 65, no. 11, pp. 1577–1589. https://doi.org/10.1111/jphp.12144
Roos, W.P. and Kaina, B., Cancer Letts., 2013, vol. 332, pp. 237–248. https://doi.org/10.1016/j.canlet.2012.01.007
Roos, W.P., Thomas, A.D., and Kaina, B., Nature Reviews Cancer, 2016, vol. 16, pp. 20–33. https://doi.org/10.1038/nrc.2015.2
Octavia, Y., Tocchetti, C.G., Gabrielson, K.L., Janssens, S., Crijns, H.J., and Moens, A.L., J. Mol. Cell. Cardiol., 2012, vol. 52, pp. 1213–1225. https://doi.org/10.1016/j.yjmcc.2012.03.006
Li, J.-Z., Yu, S.-Y., Wu, J.-H., Shao, Q.-R., and Dong, X.-M., Can. J. Physiol. Pharmacol., 2012, vol. 90, no. 12, pp. 1569–1575. https://doi.org/10.1139/y2012-140
Oesterle, A., Laufs, U., and Liao, J.K., Circulation Res., 2017, vol. 120, no. 1, pp. 229–243. https://doi.org/10.1161/circresaha.116.308537
Carrizzo, A., Forte, M., Lembo, M., Formisano, L., Puca, A.A., and Vecchione, C., Current Drug Targets, 2014, vol. 15, no. 13, pp. 1231–1246. https://doi.org/10.2174/1389450115666141027110156
Hajas, G., Bacsi, A., Aguilera-Aguirre, L., Hegde, M.L., Tapas, K.H., Sur, S., Radak, Z., Ba, X., and Boldogh, I., Free Rad. Biol. Med., 2013, vol. 61, pp. 384–394. https://doi.org/10.1016/j.freeradbiomed.2013.04.011
Marei, H. and Malliri, A., Small GTPases, 2017, vol. 8, no. 2, pp. 90–99. https://doi.org/10.1080/21541248.2016.1202635
Huelsenbeck, S.C., Schorr, A., Roos, W.P., Huelsenbeck, J., Henninger, C., Kaina, B., and Fritz, G., J. B-iol. Chem., 2012, vol. 287, pp. 38590–38599. https://doi.org/10.1074/jbc.m112.377903
Fritz, G. and Henninger, C., Biomolecules, 2015, vol. 5, pp. 2417–2434. https://doi.org/10.3390/biom5042417
Henninger, C. and Fritz, G., Cell Death and Disease, 2017, vol. 8, e2564. https://doi.org/10.1038/cddis.2016.418
Nadeev, A.D. and Goncharov, N.V., Complex Problems of Cardiovascular Diseases, 2014, vol. 4, pp. 80–94.
Wang, L., Chen, Q., Qi, H., Wang, C., Wang, C., Zhang, J., and Dong, L., Cancer Res., 2016, vol. 76, no. 22, pp. 6631–6642. https://doi.org/10.1158/0008-5472.CAN-15-3034
Riad, A., Bien, S., Gratz, M., Escher, F., Wester-mann, D., Heimesaat, M.M., Bereswill, S., Krieg, T., Felix, S.B., Schultheiss, H.P., Kroemer, H.K., and Tschöpe, C., Eur. J. Heart Failure, 2008, vol. 10, no. 3, pp. 233–243. https://doi.org/10.1016/j.ejheart.2008.01.004
Vranková, S., Barta, A., Klimentová, J., Dovinová, I., Líšková, S., Dobešová, Z., Pecháňová, O., Kuneš, J., and Zicha J., Oxidative Medicine and Cellular Longevity, 2016, vol. 2016, article ID 9814038. https://doi.org/10.1155/2016/9814038
Wardyn, J.D., Ponsford, A.H., and Sanderson, C.M., Biochem. Soc. Trans., 2015, vol. 43, no. 4, pp. 621–626.
Bellezza, I., Giambanco, I., Minelli, A., and Donato, R., Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 2018, vol. 1865, no. 5, pp. 721–733.
Volkova, M. and Russell, R., Curr. Cardiol. Revs., 2011, vol. 7, no. 4, pp. 214–220. https://doi.org/10.2174/157340311799960645
Conklin, K.A., J. Nutrition, 2014, vol. 134, no. 11, 3201S–3204S. https://doi.org/10.1093/jn/134.11.3201s
Pozhilova, Y.V., Novikov, V.E., and Levchenkova, O.S., Reviews on Clinical Pharmacology and Drug Therapy, 2014, vol. 12, no. 3, pp. 13–19. https://doi.org/10.17816/RCF12313-19
Angsutararux, P., Luanpitpong, S., and Issaragrisil, S., Oxidative Medicine and Cellular Longevity, 2015, vol. 2015, article ID 795602. https://doi.org/10.1155/2015/795602
Mong, M.-C., Hsia, T.-C., and Yin, M.-C., J. Food Sci., 2013, vol. 78, no. 10, pp. H1621–H1628. https://doi.org/10.1111/1750-3841.12257
Valeev V.V., Trashkov A.P., Kovalenko A.L., Petrov A.Y., Vasiliev A.G., Patol. Fiziol. Ekspr. Ter., 2016, vol. 60, no. 4, pp. 52–57. https://doi.org/10.25557/0031-2991.2016.04.52-57
Vershinina, E.O., Salnikova, E.S., and Repin, A.N., Siberian Medical Journal, 2014, vol. 29, no. 4, pp. 6–12. https://doi.org/10.29001/2073-8552-2014-29-4-6-12
Gogolashvili, N.G., Russian Journal of Cardiology, 2018, vol. 154, no. 2, pp. 134–149. https://doi.org/10.15829/1560-4071-2018-2-134-149
Lee, M.M.Y., Sattar, N., McMurray, J.J.V., and Packard, C.J., Current Atherosclerosis Reports, 2019, vol. 21, no. 41, 8 pages. https://doi.org/10.1007/s11883-019-0800-z
Riad, A., Bien, S., Westermann, D., Becher, P.M., Loya, K., Landmesser, U., Kroemer, H.K., Schultheiss, H.P., and Tschöpe, C., Cancer Res., 2009, vol. 69, pp. 695–699. https://doi.org/10.1158/0008-5472.can-08-3076
Huelsenbeck, J., Henninger, C., Schad, A., Lackner, K.J., Kaina, B., and Fritz, G., Cell Death and Disease, 2011, vol. 2, e190. https://doi.org/10.1038/cddis.2011.65
Acar, Z., Kale, A., Turgut, M., Demircan, S., Durna, K., Demir, S., Meriç, M., and Ağaç, M.T., J. Am. College Cardiol., 2011, vol. 58, pp. 988–989. https://doi.org/10.1016/j.jacc.2011.05.025
Kim, Y.H., Park, S.M., Kim, M., Kim, S.H., Lim, S.Y., Ahn, J.C., Song, W.H., and Shim, W.J., Toxicology Mechanisms and Methods, 2012, vol. 22, no. 6, pp. 488–498. https://doi.org/10.3109/15376516.2012.678406
Kalam, K. and Marwick, T.H., Eur. J. Cancer, 2013, vol. 49, no. 13, pp. 2900–2909. https://doi.org/10.1016/j.ejca.2013.04.030
Merino, P., Maiuolo, L., Delso, I., Algieri, V., de Nino, A., and Tejero, T., RSC Advances, 2017, vol. 7, pp. 10947–10967. https://doi.org/10.1039/c6ra28316k
Weitz-Schmidt, G., Welzenbach, K., Dawson, J., and Kallen, J., J. Biol. Chem., 2004, vol. 279, no. 45, pp. 46764–46771. https://doi.org/10.1074/jbc.m407951200
Stach, K., Nguyen, X.D., Lang, S., Elmas, E., Weiss, C., Borggrefe, M., Fischer, J., and Kälsch, T., Cardiology J., 2012, vol. 19, no. 1, pp. 20–28. https://doi.org/10.5603/cj.2012.0005
Wassmann, S., Laufs, U., Müller, K., Konkol, C., Ahlbory, K., Bäumer, A.T., Linz, W., Böhm, M., and Nickenig, G., Arteriosclerosis, Thrombosis and Vascular Biology, 2002, vol. 22, no. 2, pp. 300–305. https://doi.org/10.1161/hq0202.104081
Thompson, P.D., Panza, G., Zaleski, A., and Taylor, B., J. Am. College Cardiol., 2016, vol. 67, no. 20, pp. 2395–2410. https://doi.org/10.1016/j.jacc.2016.02.071
Spence, D.J. and Dresser, G.K., J. Am. Heart Assoc., 2016, vol. 5, e002497. https://doi.org/10.1161/jaha.115.002497
Kazakov, R.E., Evteev, V.A., Muslimova, O.V., Mazarkina, I.A., and Demchenkova, E.Yu., International Journal of Applied and Fundamental Research, 2016, vol. 8, pp. 691–698.
Venardos, N., Deng, X.S., Yao, Q., Weyant, M.J., Reece, T.B., Meng, X., and Fullerton, D.A., J. Surgical Res., 2018, vol. 230, pp. 101–109. https://doi.org/10.1016/j.jss.2018.04.054
Teplyakov, A.T., Svarovskaya, A.V., Suslova, T.E., Gusakova, A.M., Lavrov, A.G., and Nasrashvili, N.V., Siberian Medical Journal, 2016, vol. 31, no. 4, pp. 13–20. https://doi.org/10.29001/2073-8552-2016-31-4-13-20
Wang, S., Cheng, Z.-Y., Chen, X.-J., and Xue, H.-Z., Eur. Rev. Med. Pharmacol. Sci., 2018, vol. 22, no. 24, pp. 8990–8998. https://doi.org/10.26355/eurrev_201812_16670
Bahrami, A., Parsamanesh, N., Atkin, S.L., Banach, M., and Sahebkar, A., Pharmacol. Res., 2018, vol. 135, pp. 230–238. https://doi.org/10.1016/j.phrs.2018.08.014
Kalashnik, D.N. and Volkov, V.I., Crimean Therapeutic Journal, 2006, vol. 3, pp. 78–81.
Lushnikova, E.L., Nikityuk, D.B., Klinnikova, M.G., Koldysheva, E.V., and Mzhelskaya, M.M., Morpholo-giya, 2016, vol. 150, no. 6, pp. 29–33.
Polegato, B.F., Minicucci, M.F., Azevedo, P.S., Carvalho, R.F., Chiuso-Minicucci, F., Pereira, E.J., Paiva, S.A.R., Zornoff, L.A.M., Okoshi, M.P., Matsubara, B.B., and Matsubara, L.S., Cellular Physiol. Biochem., 2015, vol. 25, no. 5, pp. 1924–1933. https://doi.org/10.1159/000374001
Spallarossa, P., Altieri, P., Garibaldi, S., Ghigliotti, G., Barisione, C., Manca, V., Fabbi, P., Ballestrero, A., Brunelli, C., and Barsotti, A., Cardiovascular Res., 2006, vol. 69, no. 3, pp. 736–745.
Kamio, K., Liu, X.D., Sugiura, H., Togo, S., Kawasaki, S., Wang, X., Ahn, Y., Hogaboam, C., and Rennard, S.I., Eur. Respiratory J., 2010, vol. 35, pp. 637–646. https://doi.org/10.1183/09031936.00134707
Izidoro-Toledo, T.C., Guimaraes, D.A., Belo, V.A., Gerlach, R.F., and Tanus-Santos, J.E., Naunyn Schmiedeberg’s Archives of Pharmacology, 2011, vol. 383, no. 6, pp. 547–554. https://doi.org/10.1007/s00210-011-0623-0
Lushnikova, E.L., Mzhelskaya, M.M., Koldysheva, E.V., and Klinnikova, M.G., Siberian Scientific Medical Journal, 2018, vol. 38, no. 6, pp. 5–12. https://doi.org/10.15372/ssmj20180601
Chen, T., Zhou, G., Zhu, Q., Liu, X., Ha, T., Kelley, J.L., Kao, R.L., Williams, D.L., and Li, C., J. Chemother., 2010, vol. 22, no. 6, pp. 402–406. https://doi.org/10.1179/joc.2010.22.6.402
Koldysheva, E.V., Klinnikova, M.G., Ivleva, E.K., Listvyagova, N.A., and Lushnikova, E.L., Modern Problems of Science and Education, 2016, no. 6.https://doi.org/10.17513/spno.25577
Nakajima, K., Sug, H., Matsuno, H., Ishisaki, A., Hirade, K., and Kozawa, O., Life Sci., 2006, vol. 79, no. 12, pp. 1214–1220. https://doi.org/10.1097/00005344-200403000-00002
Dichtl, W., Dulak, J., Frick, M., Alber, H.F., Schwarzacher, S.P., Ares, M.P.S., Nilsson, J., Pachinger, O., and Weidinger, F., Arteriosclerosis, Thrombosis, Vascular and Biology, 2003, vol. 23, no. 1, pp. 58–63. https://doi.org/10.1161/01.atv.0000043456.48735.20
Hisada, T., Ayaori, M., Ohrui, N., Nakashima, H., Nakaya, K., Uto-Kondo, H., Yakushiji, E., Takiguchi, S., Terao, Y., Miyamoto, Y., Adachi, T., Nakamura, H., Ohsuzu, F., Ikewaki, K., and Sakurai, Y., Cardiovasc. Res., 2012, vol. 95, pp. 251–259. https://doi.org/10.1093/cvr/cvs110
Mason, P.R., Walter, M.F., and Jacob, R.F., Circulation, 2004, vol. 109, pp. II34–II41. https://doi.org/10.1161/01.cir.0000129503.62747.03
Mason, P.R. and Jacob, R.F., Circulation, 2003, vol. 107, no. 17, pp. 2270–2273.
Li, R., Fang, W., Cao, S., Li, Y., Wang, J., Xi, S., Zhang, B., and He, Y., Pharmazie, 2013, vol. 68, no. 4, pp. 261–269.
Tycinska, A.M., Janica, J., Mroczko, B., Musial, W.J., Sawicki, R., Sobkowicz, B., Kaminski, K., Lebkowska, U., and Szmitkowski, M., Arch. Med. Sci., 2011, no. 6, pp. 955–962. https://doi.org/10.5114/aoms.2011.26606
Ventura-Clapier, R., Garnier, A., and Veksler, V., J. Physiol., 2003, vol. 555, no. 1, pp. 1–13. https://doi.org/10.1113/jphysiol.2003.055095
Kuchmenko, E.B., Bulletin of the Novosibirsk State Pedagogical University, 2013, vol. 15, no. 5, pp. 79–94.
Alexandrov, A.A., Yadrikhinskaya, M.N., Kukharenko, S.S., and Shatskaya, O.A., Diabetes Mellitus, 2012, no. 2, pp. 70–76.
Drapkina, O.M., Rational Pharmacotherapy in Cardiology, 2013, vol. 9, no. 4, pp. 444–447. https://doi.org/10.20996/1819-6446-2013-9-4-444-447
Jiang, Z., Yu, B., and Li, Y., Medical Science Monitor, 2016, vol. 22, pp. 2825–2830. https://doi.org/10.12659/msm.897047
Gruzdeva, O.V., Borodkina, D.A., Belik, E.V., Akbasheva, O.E., Palicheva, E.I., and Barbarash, O.L., Cardiology, 2019, vol. 59, no. 3, pp. 60–67. https://doi.org/10.18087/cardio.2019.3.10220
Seo, M., Inoue, I., Ikeda, M., Nakano, T., Takahashi, S., Katayama, S., and Komoda, T., PPAR Research, 2008, article ID 316306, https://doi.org/10.1155/2008/316306
Nikolaevich, L.N. and Morozova, E.V., News of the National Academy of Sciences of Belarus. A Series of Biological Sciences, 2011, no. 1, pp. 92–96.
Rahmatollahi, M., Baram, S.M., Rahimian, R., Saeedi Saravi, S.S., and Dehpour, A.R., Cardiovasc. Toxicol., 2016, vol. 16, no. 3, pp. 244–250. https://doi.org/10.1007/s12012-015-9332-0
Yano, M., Matsumura, T., Senokuchi, T., Ishii, N., Murata, Y., Taketa, K., Motoshima, H., Taguchi, T., Sonoda, K., Kukidome, D., Takuwa, Y., Kawada, T., Brownlee, M., Nishikawa, T., and Araki, E., Circulation Res., 2007, vol. 100, no. 10, pp. 1442–1451. https://doi.org/10.1161/01.res.0000268411.49545.9c
Yokoyama, C., Aoyama, T., Ido, T., Kakino, A., Shiraki, T., Tanaka, T., Nishigaki, K., Hasegawa, A., Fujita, Y., Sawamura, T., and Minatoguchi, S., PLoS One, 2016, vol. 11, no. 5, e0154994. https://doi.org/10.1371/journal.pone.0154994
Zhang, L., Cheng, L., Wang, Q., Zhou, D., Wu, Z., Shen, L., Zhang, L., and Zhu, J., Acta Biochimica et Biophysica Sinica (Shanghai), 2015, vol. 47, no. 3, pp. 174–182. https://doi.org/10.1093/abbs/gmu131
Pacher, P., Liaudet, L., Bai, P., Virag, L., Mabley, J.G., Hasko, G., and Szabo, C., J. Pharmacol. Exper. Ther., 2002, vol. 300, no. 3, pp. 862–867. https://doi.org/10.1124/jpet.300.3.862
Kalivendi, S.V., Konorev, E.A., Cunningham, S., Vanamala, S.K., Kaji, E.H., Joseph, J., and Kalyanaraman, B., Biochem. J., 2005, vol. 389, pp. 527–539. https://doi.org/10.1042/bj20050285
Shati, A.A., Clin. Exper. Pharmacol. Physiol., 2020, vol. 47, pp. 660–676. https://doi.org/10.1111/1440-1681.13225
Ikeda, S., Matsushima, S., Okabe, K., Ikeda, M., Ishikita, A., Tadokoro, T., Enzan, N., Yamamoto, T., Sada, M., Deguchi, H., Morimoto, S., Ide, T., and Tsutsui, H., Sci. Reps., 2019, vol. 9, 9850. https://doi.org/10.1038/s41598-019-46367-6
Wen, S.-Y., Tsai, C.-Y., Pai, P.-Y., Chen, Y.-W., Yang, Y.-C., Aneja, R., Huang, C.-Y., and Kuo, W.-W., Environ. Toxicol., 2018, vol. 33, no. 1, pp. 93–103. https://doi.org/10.1002/tox.22500
Wang, S., Song, P., and Zou, M.H., J. Biol. Chem., 2012, vol. 287, no. 11, pp. 8001–8012. https://doi.org/10.1074/jbc.m111.315812
Morisco, C., Seta, K., Hard, S.E., Lee, Y., Vatner, S.F., and Sadoshima, J., J. Biol. Chem., 2001, vol. 276, no. 30, pp. 28586–28597. https://doi.org/10.1074/jbc.m103166200
Kobayashi, S., Lackey, T., Huang, Y., Bisping, E., Pu, W.T., Boxer, L.M., and Liang, Q., FASEB J., 2006, vol. 20, no. 6, pp. 800–802. https://doi.org/10.1096/fj.05-5426fje
Krysko, D.V., Kaczmarek, A., Krysko, O., Heyndrickx, L., Woznicki, J., Bogaert, P., Cauwels, A., Takahashi, N., Magez, S., Bachert, C., and Vandenabeele, P., Cell Death Differentiation, 2011, vol. 18, pp. 1316–1325. https://doi.org/10.1038/cdd.2011.4
Parakhonsky, A.P., Basic Research, 2006, no. 3, pp. 67–68.
Bootman, M.D., Chehab, T., Bultynck, G., Parys, J.B., and Rietdorf, K., Cell Calcium, 2018, vol. 70, pp. 32–46. https://doi.org/10.1016/j.ceca.2017.08.005
Kobayashi, S., Volden, P., Timm, D., Mao, K., Xu, X., and Liang, Q., J. Biol. Chem., 2010, vol. 285, no 1, pp. 793–804. https://doi.org/10.1074/jbc.m109.070037
Sabe, A.A., Elmadhun, N.Y., Sadek, A.A., Chu, L.M., Bianchi, C., and Sellke, F.W., J. Thor. Cardiovasc. Surg., 2014, vol. 148, no. 6, pp. 3172–3178. https://doi.org/10.1016/j.jtcvs.2014.07.104
Andres, A.M., Hernandez, G., Lee, P., Huang, C., Ratliff, E.P., Sin, J., Thornton, C.A., Damasco, M.V., and Gottlieb, R.A., Antioxidant Redox Signaling, 2014, vol. 21, no. 14, pp. 1960–1973. https://doi.org/10.1089/ars.2013.5416
Liu, D., Cui, W., Liu, B., Hu, H., Liu, J., Xie, R., Yang, X., Gu, G., Zhang, J., and Zheng H., Cell. Physiol. Biochem., 2014, vol. 33, no. 1, pp. 129–141. https://doi.org/10.1159/000356656
Koyuturk, M., Ersöz, M., and Altiok, N., Cancer Letts., 2007, vol. 250, no. 2, pp. 220–228. https://doi.org/10.1016/j.canlet.2006.10.009
Radyukova, I.M., Druk, I.V., Nechaeva, G.I., Korennova, O.Yu., Reznikov, A.S., and Merkulov, V.N., Siberian Journal of Oncology, 2012, vol. 50, no. 2, pp. 73–78.
Chan, K.K., Oza, A.M., and Siu, L.L., Clin. Cancer Res., 2003, vol. 9, no. 1, pp. 10–19.
Sassano, A., and Platanias, L.C., Cancer Letts., 2008, vol. 260, nos. 1–2, pp. 11–19. https://doi.org/10.1016/j.canlet.2007.11.036
Klaan, N.K., Pronina, T.A., Akinshina, L.P., and Reshetnikova, V.V., Russian Journal of Biotherapy, 2014, vol. 13, no. 1, pp. 3–8.
Lersch, C., Schmelz, R., Erdmann, J., Hollweck, R., Schulte-Frohlinde, E., Eckel, F., Nader, M., and Schusdziarra, V., Hepatogastroenterology, 2004, vol. 51, no. 58, pp. 1099–1103.
Liu,Y., Qin, A., Li, T., Qin, X., and Li, S., Gynecologic Oncology, 2014, vol. 133, no. 3, pp. 647–655. https://doi.org/10.1016/j.ygyno.2014.04.007
Cho, S.J., Kim, J.S., Kim, J.M., Lee, J.Y., Jung, H.C., and Song, I.S., Int. J. Cancer, 2008, vol. 123, pp. 951–957. https://doi.org/10.1002/ijc.23593
Gao, J., Jia, W.D., Li, J.S., Wang, W., Xu, G.L., Ma, J.L., Ge, Y.S., Yu, J.H., Ren, W.H., Liu, W.B., and Zhang, C.H., J. Int. Med. Res., 2010, vol. 38, pp. 1413–1427. https://doi.org/10.1177/147323001003800423
Kochuparambil, S.T., Al-Husein, B., Goc, A., Soliman, S., and Somanath, P.R., J. Pharmacol. Exper. Ther., 2011, vol. 336, pp. 496–505. https://doi.org/10.1124/jpet.110.174870
Funding
The work was carried out within the framework of funding under the State assignment of the Program “Cellular and molecular mechanisms of damage and remodeling of tissues and organs in metabolic disorders and toxic effects, development of technologies for stimulating cytoprotective reactions and tissue-specific reparative regeneration.” The scientific theme code: 0535-2019-0028, the State registration number AAAA-A19-119020790017-9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This work does not contain any research using humans and animals as research objects.
CONFLICT OF INTEREST
The authors declare that they have no conflicts of interest.
Additional information
Translated by A. Medvedev
Abbreviations used: AIF—apoptosis inducing factor; Akt—RAC-alpha serine/threonine-protein kinase; AMPK—AMP-activated protein kinase; AP-1—activator protein-1; Apaf-1—аpoptotic protease activating factor 1; ER—endoplasmic reticulum ; ET-1—endothelin; Fas/Fasl—the system of the Fas receptor, apoptosis antigen 1 and its Fasl ligand; FPP—farnesyl pyrophosphate; GAPs—GTPase-activating proteins; GEFs—ganine nucleotide exchange factors; GGPP—geranylgeranyl pyrophosphate; GLUT-1, GLUT-4—glucose transporters-1, -4; GSH—reduced glutathione; GSK-3b—glycogen synthase kinase 3 beta; HbA (1с)—glycated hemoglobin; HIF-1—hypoxia-inducible factor-1; HMGB1—high-mobility group protein B1; HMG-CoA reductase—hydroxymethylglutaryl coenzyme A reductase; ICAM-1—inter-cellular adhesion molecule 1; IL-1, -2, -6, -8, ‑18—interleukins; LDL—low-density lipoprotein; LFA-1—lymphocyte function-associated antigen 1, containing an allosteric site termed as the lovastatin site (L-site); Lp-PLA2—lipoprotein-associated phospholipase A2; LOX-1—lectin-like oxidized low-density lipoprotein receptor-1; МАРК—mitogen-activated protein kinase (mitogen-activated protein kinases; JNK, ERK, p38 MAPK); МСР-1—monocyte chemoattractant protein-1; MMPs—matrix metalloproteinases; mTOR—mammalian target of rapamycin; NFAT-1,-2,-4—nuclear factor of activated T-cells; NF-κB—nucleus factor kappa B; NO—nitric oxide; NOO–—peroxynitrite; NOS—nitrogen oxide synthase: (еNOS—endothelial nitrogen oxide synthase; iNOS—inducible nitrogen oxide synthase); Nrf2—nuclear factor erythroid 2‑related factor 2, nuclear E2-related factor 2; oxLDL—oxidized low-density lipoprotein cholesterol; p91phox, p22phox, p67phox, p47phox, p40phox—cytosolic proteins, subunits of NAD(P)H-oxidase; pCAMK II—calmodulin-dependent protein kinase II; PI3K—phosphoinositide 3-kinase; PPARs—peroxisome proliferator-activated receptors; PTEN—phosphatase and tensin homolog; Rho, Cdс42, Rac1, RhoA (Rac2)—monomeric G-proteins of the GTPase family; Rho-GTPases—Ras-homologous GTPases; RNS—reactive nitrogen species; Rock – RhoA-associated protein kinase; ROS—reactive oxygen species; S6K1—ribosomal protein kinase S6 beta-1; SERKA—Ca2+-ATPase; SIRT1—deacetylase sirtuin 1; SOD—superoxide dismutase; TGF-β1—transforming growth factor beta; TLR2, TLR4, TLR9—Toll-like receptors-2, -4, -9; TNFα—tumor necrosis factor α ; Top II—topoisomerase II; VCAM-1—vascular cell adhesion molecule 1; VEGF—vascular endothelial growth factor; VEGFR2—vascular endothelial growth factor receptor 2.
Rights and permissions
About this article
Cite this article
Tursunova, N.V., Klinnikova, M.G., Babenko, O.A. et al. Molecular Mechanisms of the Cardiotoxic Action of Anthracycline Antibiotics and Statin-Induced Cytoprotective Reactions of Cardiomyocytes. Biochem. Moscow Suppl. Ser. B 15, 89–104 (2021). https://doi.org/10.1134/S1990750821020116
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750821020116